Try our Advanced Search for more refined results
Health
-
April 28, 2026
Ga. Parents Say Child's $37M Death Verdict Wrongly Reduced
A couple whose son died during lymphoma treatment at a university medical center told a Georgia appellate panel Tuesday that a trial court misinterpreted the state's tort claims act when it reduced a verdict in their favor from $37 million to $2 million.
-
April 28, 2026
Eli Lilly Inks $2.25B AI Genetics Research Pact With Profluent
AI-focused biotech Profluent said Tuesday it has entered a multiprogram, strategic research collaboration with Eli Lilly and Co. to treat diseases with high unmet need, in a deal that involves an upfront payment and up to $2.25 billion in additional milestone payments.
-
April 28, 2026
Meet The Attys Arguing The High Court 'Skinny Label' Case
When the U.S. Supreme Court hears arguments Wednesday in a patent case involving "skinny labels" on generic drugs, a longtime patent attorney as well as a government attorney who often handles intellectual property cases will face an appellate specialist who has argued many high court cases.
-
April 28, 2026
Anti-Pot Group Says CMS Violated APA With Hemp Program
A group of advocates opposed to legal cannabis, as well as a cannabinoid company and two individuals, are fighting the government's bid to halt their challenge to a program to give Medicare beneficiaries access to federally legal hemp products, saying the Centers for Medicare & Medicaid Services violated federal law by instituting the program without notice or comment.
-
April 28, 2026
BREAKING: Jury Clears Armistice Capital, Execs Of Securities Fraud
A California federal jury on Tuesday cleared Armistice Capital and two of its executives on class action claims it pumped and dumped $250 million in Vaxart stock during the COVID-19 pandemic and violated federal securities law with insider trading.
-
April 27, 2026
North Dakota Drug-Pricing Law Blocked In Pharma Fight
A North Dakota federal judge on Monday blocked the state's new drug-pricing law, agreeing with pharmaceutical companies that while the law purports to "protect the underdogs," it illegally interferes with the federal drug-pricing regime.
-
April 27, 2026
DOJ Says Wash. 340B Drug Law Is Preempted In Novartis Suit
The U.S. Department of Justice waded into a dispute between pharmaceutical giants and the state of Washington on Monday, arguing that federal law preempts a new state law that expands discounts that drugmakers must provide under the federal 340B Drug Pricing Program.
-
April 27, 2026
Sullivan & Cromwell Alum Returns After 5 Years With DOJ
A former Sullivan & Cromwell attorney is returning to the firm after five years in the public sector working for the U.S. Department of Justice's criminal division, where he prosecuted high-profile insider trading cases and secured convictions for two former Merrill Lynch traders accused of manipulating the precious metals market.
-
April 27, 2026
Wyoming's Latest Near-Total Abortion Ban Blocked
A Wyoming judge has blocked enforcement of the latest effort by state lawmakers to enact a rigid anti-abortion law, after the Wyoming Supreme Court in January struck down the state's previous near-total ban on abortion.
-
April 27, 2026
'General Hospital' Actor Can't Revive Vax Suit Against ABC
California appellate justices refused to reinstate a "General Hospital" actor's suit alleging ABC fired him for his political views after he declined to comply with its COVID-19 vaccine policy, ruling the evidence shows that the ultimate decision-makers who ended his employment agreement didn't know about his political views.
-
April 27, 2026
ER Docs Urge Justices To Back 5th Circ. Revival Of BCBS Suit
Emergency room doctors urged the U.S. Supreme Court on Monday not to disturb a Fifth Circuit decision reviving their insurance reimbursement dispute against Blue Cross Blue Shield involving out-of-network claims from employee benefit plans, arguing the appellate court correctly restarted proceedings in the case.
-
April 27, 2026
Nursing Home Hit With Wage Suit Over Meal, OT Pay
Two former caregivers have hit a Michigan assisted living and memory care facility with a proposed collective action, alleging the facility failed to properly pay overtime by requiring hourly employees to work through unpaid meal breaks and excluding bonuses from overtime calculations.
-
April 27, 2026
Attys, Advocates Call DOJ Pot Rule Historic Shift For Feds
Legal strategies are evolving quickly in the wake of last week's "historic" rescheduling of state-legal medical cannabis, as a group of attorneys and advocates gathered Monday to evaluate the trade-offs of dispensaries now being able to register like pharmacies with the feds and the potential effect on industry investments and trade.
-
April 27, 2026
IQVIA Accuses Ex-Execs, Syneos Of Poaching $180M Client
IQVIA Holdings Inc. is accusing former executives of defecting to a competitor in the clinical research organization industry and initiating a corporate raid that resulted in the loss of one customer worth at least $180 million, according to a lawsuit filed in North Carolina Business Court.
-
April 27, 2026
4 Firms Build Astorg's $1.1B Microbiology Biz Buy
Life sciences company Thermo Fisher Scientific Inc. on Monday announced plans to sell its microbiology business to European private equity firm Astorg in an over $1.1 billion deal steered by four law firms.
-
April 27, 2026
Ex-Federal Workers Seek Reinstatement In Md. Federal Court
The Trump administration disguised ideologically motivated firings as routine layoffs, then pushed workers into a broken system to challenge their discharges, a group of laid-off federal workers alleged, asking a Maryland federal judge to deem the layoffs unconstitutional and reinstate the workers to their former positions.
-
April 27, 2026
Cannabis Co. Can't Shift Atty AI Sanctions To Rival Company
A Florida federal judge will not force a medical marijuana company to accept liability for sanctions incurred by its in-house counsel over the misuse of generative artificial intelligence, rejecting a rival company's arguments that the lawyer previously avoided monetary sanctions for filing errors and was likely to do so again.
-
April 27, 2026
Convicted Pa. Dentist Says Feds Failed To Prove Fraud
A Pennsylvania dentist convicted along with his brother for using their dental practice to defraud Medicare, install unapproved dental implants in patients, and falsify visas to recruit foreign workers has asked a federal judge for acquittal or a new trial, arguing the government failed to show he committed any crimes.
-
April 27, 2026
Medical Group Says Secret Call Could Upend Estate's Verdict
A Connecticut anesthesiology group has asked a state appeals court to reverse its portion of a $20 million wrongful death verdict, saying a lower court judge should have allowed into evidence a secret phone recording of a surgeon, used different verdict forms and blocked testimony from an allegedly unqualified witness.
-
April 27, 2026
What To Watch As Justices Take On 'Skinny Label' Case
The U.S. Supreme Court will hear arguments Wednesday on whether to permit a patent suit over a generic heart drug using a so-called skinny label, a case with ramifications for the drug industry that could shape patent disputes more broadly and other legal areas. Here's what to watch for.
-
April 27, 2026
4th Circ. Says Medicaid Fraud Convictions Lacked Evidence
The government failed to prove the former owner of a mental health counseling company in Virginia willfully committed fraud by falsely billing Medicaid $200,000 for counseling services on two specific dates, a panel of the Fourth Circuit has found, overturning his convictions.
-
April 27, 2026
Ropes & Gray, Cooley Lead Lilly's $2.3B Cancer Drug Buy
Eli Lilly and Co. said Monday it will acquire privately held Ajax Therapeutics in a deal worth up to $2.3 billion, as the drugmaker looks to expand its pipeline of treatments for blood cancers.
-
April 27, 2026
US, Indian Firms Guide $11.75B Sun Pharma-Organon Deal
Indian pharmaceutical giant Sun Pharmaceutical Industries Ltd. has agreed to acquire New Jersey-based Organon & Co. in an all-cash deal valued at $11.75 billion, with each side of the transaction having representation from one U.S. and one Indian law firm.
-
April 24, 2026
Disability Groups Back Psilocybin Home Access In Ore.
The Oregon Health Authority's refusal to allow home-based psilocybin services for terminally ill patients who cannot travel violates federal law, a coalition of disability rights groups have told an Oregon federal court in a brief in favor of broadening the state's psilocybin access program.
-
April 24, 2026
Tenn. Abortion Ban Trial Taken Off Calendar Following Appeal
A Tennessee state court has canceled a trial scheduled to begin Monday over a suit challenging the state's abortion ban and seeking clarification on when a physician can legally terminate a high-risk pregnancy.
Expert Analysis
-
How The Coming Months Will Shape State Drug Price Boards
The future of state prescription drug affordability boards may be determined in the next few months, between an upcoming court decision in a challenge against state authority to set drug prices, and pending state decisions about whether to use federal Medicare maximum fair prices as reference, say Michael Kolber, Steven Chen and Kelechi Ezealaji at Manatt.
-
High Court 'Skinny Label' Case Will Matter To Tech Litigators
Hikma v. Amarin, set for oral argument in the U.S. Supreme Court on Wednesday, has potential to affect not just generic drug label-based evidence in patent cases, but also how technology inducement cases are presented and proven, says attorney Abdul Abdullahi.
-
Steps To Consider As DOJ Launches Fraud Division
The establishment this month of the National Fraud Enforcement Division within the U.S. Department of Justice is a significant reorganization that suggests an increase in enforcement activity involving federally funded programs but leaves a number of important questions unanswered, say attorneys at Crowell & Moring.
-
Court's HRSA Policy Reversal Leaves 340B Rules Murky
A D.C. federal court's recent decision in Premier v. U.S. Department of Health limits the Health Resources and Services Administration's ability to enforce long-standing Section 340B interpretations through subregulatory guidance, leaving open core statutory questions about purchasing models, inventory classification and program oversight, says Martha Cramer at Hooper Lundy.
-
Opinion
DOJ Delay Of ADA Web Rule Undermines Equal Access
The U.S. Department of Justice's recent decision to delay compliance dates for regulations ensuring accessible government services online benefits no one, as it is long overdue for disabled Americans and doesn't lessen covered entities' legal obligations or litigation risk, say Mark Riccobono at the National Federation of the Blind and Eve Hill at Brown Goldstein.
-
Series
Officiating Football Makes Me A Better Lawyer
Though they may seem to have little in common, officiating football has sharpened many of the same skills that define effective lawyering in management-side labor and employment: preparation, judgment, composure, credibility and ability to make difficult decisions in real time, says Josh Nadreau at Fisher Phillips.
-
Fresenius Ruling May Shift Anti-Kickback Enforcement
The Ninth Circuit's recent decision in Fresenius v. Bonta suggests that businesses have a First Amendment right to donate to certain charities, even if those donations are motivated by economic self-interest, potentially calling into question years of Anti-Kickback Statute proceedings against pharmaceutical manufacturers for making similar donations, says Jonah Knobler at Patterson Belknap.
-
Written Consent Ruling May Signal Change For Telemarketing
The Fifth Circuit's ruling in Bradford v. Sovereign Pest Control is a takedown of the Federal Communications Commission's prior express written consent regulation, and because Loper Bright empowers courts to disregard agency interpretations, Telephone Consumer Protection Act litigants now have an opportunity to challenge previously settled FCC regulations, orders and interpretations, say attorneys at Manatt.
-
Series
Law School's Missed Lessons: How To Draft Pleadings
Most law school graduates step into their first jobs without ever having drafted a complaint, answer, motion or other type of pleading, but that gap can be closed by understanding the strategy embedded in every filing, writing with clarity and purpose, and seeking feedback at every step, says Eric Yakaitis at Haug Barron.
-
E-Discovery Quarterly: Recent Rulings On ESI Control
Several recent federal court decisions have perpetuated a split over what constitutes “control” of electronically stored information — with judges divided on whether the standard should turn on a party's legal right or practical ability to obtain the information, say attorneys at Sidley.
-
The Challenge Of Stabilizing Rural Hospitals On The Brink
The outlook for rural hospitals has grown more concerning, as recent policy and regulatory developments are decreasing hospital revenues and increasing the cost of uncompensated care, which may result in additional hospital closures, service reductions, or mergers and acquisitions, say Omur Celmanbet, Kristy Piccinini and Sabiha Quddus at FTI Consulting.
-
Insurer Lessons From 1st Wave Of GenAI Coverage Rulings
Several pending cases target the issue of whether generative AI may appropriately replace human professional decision-making, and though each case is still in discovery, the decisions thus far provide insurers with guidance on how courts may view these claims, say attorneys at Simpson Thacher.
-
The Role Of Operational Data In Tech Platform Liability Suits
As litigation becomes a de facto substitute for the regulation of major technology platforms, with plaintiffs advancing claims under product liability, public nuisance and consumer protection laws, among others, courts are evaluating how platform systems operate in practice based on large-scale operational data, say attorneys at Brattle.
-
2 Discovery Rulings Break With Heppner On AI Privilege Issue
While a New York federal court’s recent ruling in U.S. v. Heppner suggests that some litigants’ communications with AI tools are discoverable, two other recent federal court decisions demonstrate that such interactions generally qualify for work-product protection under the Federal Rules of Civil Procedure, says Joshua Dunn at Brown Rudnick.
-
Bid Protest Spotlight: Evidence, Tailored Talks, Materiality
In this month's bid protest roundup, Brian Doll at MoFo delves into three recent decisions from the Government Accountability Office about the evidentiary standards necessary to sustain a protest, discussions tailored to individual proposals, and misrepresentation claims involving factors irrelevant to the agency's decision.